Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection
Fields of Study & Subjects
interferon and immune responses
Respiratory viral infections research
SARS-CoV-2 and COVID-19 Research
Publication details
- Journal / source
- Nature Nanotechnology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 21
- Issue
- 7
- Pages
- 1008–1021
- Publication date
- 17 June 2026
- Language
- EN